Abstract:Stimuli-responsive nanocarriers attract wide attention because of the unique differences in microenvironment between solid tumors and normal tissues. Herein, we reported a novel cRGDyK peptide modified pH-sensitive nanoparticle system based on poly(ethylene glycol)-poly(2,4,6-trimethoxy benzylidene-pentaerythritol carbonate) (PEG-PTMBPEC) diblock copolymer, which was expected to destroy tumor angiogenesis and kill tumor cells simultaneously. Doxorubicin (DOX)-loaded nanoparticles (NPs) were characterized to have a uniform size distribution, high entrapment efficiency, good stability in plasma as well as a pH dependent drug release pattern. Blank NPs were non-toxic to both tumor cells and normal cells, while DOX-loaded cRGDyK peptide modified NPs (cRGDyK-NPs) exhibited the pronounced cytotoxicity against B16 cells and human umbilical vein endothelial cells (HUVEC) overexpressing alpha(v)beta(3) integrin receptors. Cellular uptake studies revealed that the highly efficient uptake of cRGDyK-NPs was attributed to the receptor-mediated endocytosis and acidic-triggered drug release. Importantly, cRGDyK-NPs could dramatically reduce the systemic toxicity of DOX and exert excellent tumor killing activity in vivo. The cRGDyK modified pH-sensitive nanocarrier is a promising vehicle for intracellular drug delivery to alpha(v)beta(3) integrin receptor overexpressed tumor cells and neovascular cells.Statement of SignificanceSlow intracellular drug release and poor tumor targeting capacity are still the critical barriers of polymeric nanoparticles (NPs) for the treatment efficiency of chemotherapy. In the present study, we designed cRGDyK peptide modified poly(ethylene glycol)-poly(2,4,6-trimethoxybenzylidene-pentaery thritol carbonate) (cRGDyK-PEG-PTMBPEC) NPs with active targeting and fast pH-triggered drug release. Doxorubicin (DOX)-loaded cRGDyK-PEG-PTMBPEC NPs exhibited pronounced cytotoxicity and enhanced cellular uptake against B16 cells and human umbilical vein endothelial cells overexpressing alpha v beta 3 integrin receptors. Moreover, the active targeted pH-sensitive NPs can enhance the antitumor activity and reduce the systematic toxicity of DOX in vivo. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

In Vitro Anticancer Activity of Doxorubicin-Loading Pectin Nanoparticles

Doxorubicin-loading core-shell pectin nanocell: A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal

Engineering Pectin-Based Hollow Nanocapsules for Delivery of Anticancer Drug.

In Vitro and in Vivo Antitumor Activity of a Novel Ph-Activated Polymeric Drug Delivery System for Doxorubicin

In vitro evaluation of anticancer nanomedicines based on doxorubicin and amphiphilic Y-shaped copolymers.

In vitro and in vivo antitumor activity of doxorubicin-loaded alginic-acid-based nanoparticles.

Nanomicelles Based on a Boronate Ester-Linked Diblock Copolymer As the Carrier of Doxorubicin with Enhanced Cellular Uptake.

Antitumor Efficacy of Doxorubicin Encapsulated Within PEGylated Poly(amidoamine) Dendrimers

Self-assembling Doxorubicin Prodrug Forming Nanoparticles for Cancer Chemotherapy: Synthesis and Anticancer Study in Vitro and in Vivo.

Doxorubicin-loaded Fluorescent Carbon Dots with PEI Passivation As a Drug Delivery System for Cancer Therapy.

PEGylated phospholipid micelles containing D-α-tocopheryl succinate as multifunctional nanocarriers for enhancing the antitumor efficacy of doxorubicin

Bioreducible Paa-G-Peg Graft Micelles with High Doxorubicin Loading for Targeted Antitumor Effect Against Mouse Breast Carcinoma

Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis

Self-Assembling pH-Responsive Nanoparticle Platform Based on Pectin–Doxorubicin Conjugates for Codelivery of Anticancer Drugs

Novel Ph-Triggered Doxorubicin-Releasing Nanoparticles Self-Assembled by Functionalized Β-Cyclodextrin and Amphiphilic Phthalocyanine for Anticancer Therapy.

Polytyrosine nanoparticles enable ultra-high loading of doxorubicin and rapid enzyme-responsive drug release.

[Preparation and in Vitro Evaluation of Doxorubicin-Loaded Magnetic Iron Oxide Nanoparticles].

Doxorubicin Loading Capacity of Shell Cross-Linked Micelles with Ph-Responsive Core As Anticancer Drug Delivery Nanocarriers

PEG-stabilized bilayer nanodisks as carriers for doxorubicin delivery.

Enhanced Antitumor Efficacy of Doxorubicin-Encapsulated Halloysite Nanotubes.

Crgdyk Modified Ph Responsive Nanoparticles for Specific Intracellular Delivery of Doxorubicin.